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Abstract
Frailty is highly prevalent in the elderly, increasing the risk of poor health outcomes. The Groningen Frailty Indicator (GFI) 
is a 15-item validated questionnaire for the elderly. Its value in patients with end-stage hip or knee osteoarthritis (OA) has 
not yet been determined. This study assesses the validity of the GFI in this patient group. End-stage hip or knee OA patients 
completed the GFI (range 0–15, ≥ 4 = frail) before arthroplasty surgery. Convergent validity was determined by Spearman-
rank correlation between the SF-12 physical (PCS) and mental (MCS) component scores and the physical and mental 
GFI-domains, respectively. Discriminant validity was assessed by means of overall GFI-score and the pain-domain of the 
Hip/Knee Osteoarthritis Outcome Score (HOOS/KOOS). Altogether 3275 patients were included of whom 2957 (90.3%) 
completed the GFI. Mean GFI-scores were 2.78 (2.41) and 2.28 (1.99) in hip and knee OA-patients, respectively, with 570 
(35.9%) of hip and 344 (24.1%) of knee patients considered frail. The convergent validity was moderate to strong (physical 
domain R = − 0.4, mental domain R = − 0.6) and discriminant validity low (R HOOS/KOOS-pain domain = − 0.2), con-
firming the validity of the GFI-questionnaire in this population. With 90% of participants completing the GFI, it is a feasible 
and valid questionnaire to assess frailty in end-stage hip and knee OA-patients. One-third (33.3%) of the patients undergoing 
hip arthroplasty and a quarter (24.1%) of those undergoing knee arthroplasty are frail. Whether this is associated with worse 
outcomes and can thus be used as a pre-operative predictor needs to be explored.
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Introduction
Osteoarthritis (OA) is a degenerative joint disease which 
often leads to disability and pain. A highly effective treat-
ment for end-stage OA is arthroplasty surgery [1, 2]. Over 
202,500 total hip and 402,100 total knee arthroplasties 
(THA and TKA) are performed annually in the United States 
of America alone [3], with the volume expected to increase 
up to sixfold by 2030 [3].
At present, 83% of the patients receiving THA and 79% 
of patients receiving TKA are older than 60 years of age 
[4]. As frailty is highly prevalent in the elderly, it is likely 
that a considerable proportion of patients undergoing THA 
or TKA are frail [5]. Although there is not one definition 
for frailty, the most often used definitions include a com-
bination of decrease of independence, strength, cognition, 
activity, energy, weight and walking speed [6–12]. Litera-
ture shows that there is considerable heterogeneity in the 
extent of frailty individuals may experience, with some per-
sons accelerating fast while others are slowly progressing 
to higher levels of frailty [13]. Within persons of the same 
age, also the onset of frailty differs per individual [14–17].
It is generally acknowledged that frailty hampers the abil-
ity to resist stressors, leading to vulnerability for adverse 
Rheumatology
INTERNATIONAL 
Claudia S. Leichtenberg, Claire Tilbury, Bart L. Kaptein, 
Lennard A. Koster, Suzan H.M. Verdegaal, Ron Onstenk, 
Henrike M.J. Linden-van der Zwaag, Herman Kaptijn, Stephan 
B.W. Vehmeijer, Willem-Jan C. Marijnissen, Pieter-Jan Damen, 
Prof. Thea P.M. Vliet Vlieland are the members of LOAS study 
group.
 * Jennifer M. T. A. Meessen 
 j.m.t.a.meessen@lumc.nl
Extended author information available on the last page of the article
918 Rheumatology International (2018) 38:917–924
1 3
outcomes after surgery [6, 16–19]. As such, it is of impor-
tance to have more insight into frailty in the group of patients 
undergoing THA or TKA. As a first step into the exploration 
of the role of frailty in the outcomes of total joint surgery, an 
appropriate instrument for frailty is needed.
The Groningen Frailty Indicator (GFI) is a frequently 
used questionnaire in the elderly to assess frailty. The advan-
tage of the GFI is that it is a self-reported score; further-
more, this questionnaire has been validated specifically for 
elderly (mean age 81 years). In these elderly (both com-
munity dwelling and institutionalized), it was found that the 
GFI is feasible, reliable and valid [20].
However, it is not known yet how feasible the GFI is in 
a clinical setting as well as the validity of the GFI amongst 
the somewhat younger patients with end-stage hip or knee 
OA waiting for arthroplasty surgery.
Therefore, in this study we aimed to assess the feasibil-
ity and validity of the GFI as a tool to measure frailty in 
end-stage hip or knee osteoarthritis patients scheduled to 
undergo arthroplasty surgery.
Methods
Study design
This study is part of the Longitudinal Leiden Orthopaedics 
Outcomes of Osteo-Arthritis study (LOAS). The LOAS 
study is an ongoing, multi-center, longitudinal prospective 
cohort study including patients undergoing primary total 
hip or knee arthroplasty (THA or TKA). Participants are 
recruited in 7 participating hospitals (the Leiden Univer-
sity Medical Center, Leiden; Alrijne Hospital, Leiden/Lei-
derdorp (former Diaconessenhuis and Rijnland Hospital); 
Groene Hart Hospital, Gouda; LangeLand Hospital, Zoeter-
meer; Reinier de Graaf Gasthuis, Delft; Albert Schweitzer 
Hospital, Dordrecht; Waterland Hospital, Purmerend). The 
LOAS study (Trial ID NTR3348) started in June 2012. The 
present study is only concerned with data gathered preop-
eratively from June 2012 to June 2016 [21].
Patients
All patients who were able to complete questionnaires in 
Dutch and who were 18 years or older were eligible for 
participation. Excluded were patients who did not provide 
informed consent, had insufficient Dutch language skills or 
of whom the physical or mental status did not allow par-
ticipation. Eligible patients were informed about the study 
through written and oral information by their treating sur-
geon at the outpatient clinic. Only patients who agreed to 
be approached by the researcher received additional written 
information about the study by regular mail or e-mail, as 
well as a questionnaire, a stamped return envelope and a 
consent form. Patients were included in the study once writ-
ten informed consent was obtained according to the Declara-
tion of Helsinki [22]. For the purpose of the present analysis 
only data from patients who returned the preoperative ques-
tionnaire between the start of the study in June 2012 until 
June 2016 were included. Ethical approval was obtained 
by the Medial Ethics Committee of the Leiden University 
Medical Center (registration number P12.047) and funding 
was received from the Dutch Arthritis Foundation (LLP13).
The questionnaires were incorporated in current clinical 
setting of the included hospitals which all participate in the 
collection of patient reported outcome measures (PROMs) 
for the national Dutch Arthroplasty Register (LROI).
Assessments
Frailty
Frailty was assessed by the Groningen Frailty Indicator 
(GFI). This questionnaire consists of 15 questions cover-
ing several aspects of life, such as independence in daily 
tasks, involuntary weight loss, medication use, mental state, 
vision and hearing. Together these questions lead to a score 
between 0 and 15, a score of ≥ 4 is considered to be frail. 
The GFI is specifically directed to elderly persons both liv-
ing at home as well as in institutions [20, 23, 24].
Overall health
Quality of life was measured using the validated Dutch ver-
sion of the Short Form (SF)-12 [25]. The SF-12 comprises 
12 items on generic measurement of the overall health-
related quality of life. Scores range from 0 to 100, with 0 
being lowest possible score and 100 the highest. From the 
SF-12, two subscales can be calculated, the physical compo-
nent score (PCS) and mental component score (MCS). These 
subdomains were assessed separately in the analyses [26].
Hip/knee symptoms
The hip disability/knee injury and osteoarthritis outcome 
score (HOOS/KOOS) questionnaires are validated question-
naires to measure the function of patients with end-stage 
osteoarthritis for hip or knee, respectively [27, 28]. These 
questionnaires comprise five domains (activities of daily 
living, quality of life, sports, symptoms and pain). For the 
current study the validated Dutch version was used [29, 30].
Statistical analyses
Patient characteristics were analysed using descriptive statis-
tics. Rates of patients who did not, partially or completely fill 
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out the GFI were computed. Comparisons between patients 
who filled in the GFI completely and those who did not or 
partially were done by means of either Chi-square tests for 
categorical variables and t tests for continuous variables. In 
addition, for each GFI item the proportion of missing values 
was determined.
To explore determinants for completing the question-
naire a binary variable “completion of questionnaire” was 
constructed. This variable was used in a logistic regression 
analysis to see if age, sex, BMI and comorbidities are of 
significant influence on the completion of the questionnaire.
The internal consistency of the GFI in this patient popu-
lation was assessed by means of Cronbach’s alpha, with an 
alpha of > 0.7 being considered as good consistency [31]. 
Convergent validity of the GFI was determined by comput-
ing correlations between the physical domain of GFI (ques-
tions 1–9) and the PCS of the SF-12. The mental domain of 
the GFI (question 14 and 15) was correlated with the MCS 
of the SF-12. Correlations were computed using a Spearman 
rank correlation coefficients. As the corresponding subscales 
of the GFI and SF-12 aim to measure similar constructs it 
was hypothesized that the correlation between the subscales 
of the GFI and SF-12 will be high.
Discriminant validity of the questionnaire was assessed 
by correlating the physical domain of the GFI to the MCS 
and the mental domain of the GFI to the PCS. Also, a spear-
man rank correlation analysis including the total GFI-score 
and pain as measured by the HOOS/KOOS questionnaire 
was performed. As the correlated constructs are conceptu-
ally different, we hypothesized the correlation between these 
domains would be low.
For those THA and TKA patients who completed the GFI 
the prevalence of frailty was calculated, based on the cut-
off score of four [24]. The demographic variables of those 
assigned frail and those not designated as frail were com-
pared by means of a t test or Chi-square test, whichever was 
appropriate. All analyses were performed with IBM SPSS 
statistics software version 23.
Results
Within the time frame of the present analysis 3275 patients 
with end-stage hip OA (N = 1691) and knee OA (N = 1584) 
were included in the cohort study. For both end-stage hip 
and knee OA, 90.3% of the participants completed the 
questionnaire. In Table 1 the socio-demographic variables 
of patients returning the questionnaire that did and did not 
complete it fully were compared. In hip OA, those who did 
not fully complete the questionnaire were significantly older, 
whereas in knee OA those who did not complete the ques-
tionnaire fully were more often female and had a lower score 
on the HOOS/KOOS-activities of daily life domain. In both 
end-stage hip and knee OA those who did not complete the 
questionnaire had a significantly lower score on the MCS.
Table 1  Characteristics of patients with end-stage hip or knee osteoarthritis undergoing total hip or knee arthroplasty who did and did not com-
plete the Groningen Frailty Indicator questionnaire (GFI)
BMI body mass index, SF-12 short form 12 questionnaire, PCS physical component score of the SF-12, MCS mental component score of the 
SF-12, HOOS/KOOS hip disability/knee injury and osteoarthritis outcome score
* Characteristics of patients who completed and those who did not complete the GFI questionnaires were tested by means of a t test (normal dis-
tribution, continue), Mann–Whitney (not-normal distribution, continue) or Chi square (discrete) variables
Hip Knee
GFI fully 
completed 
N = 1527
GFI not 
completed 
N = 164
P value* GFI fully 
completed 
N = 1430
GFI not 
completed 
N = 154
P value*
Sex Female N (%) 925 61.5% 107 67.3% 0.155 911 64.2% 119 77.3% 0.001
Age Years Mean (SD) 67.8 9.8 70.9 9.4 < 0.001 67.4 8.9 67.6 9.1 0.818
BMI Mean (SD) 27.2 4.3 27.0 5.4 0.529 29.4 4.7 29.0 4.4 0.373
Living Not alone N (%) 1187 77.7% 118 71.9% 0.097 1095 76.5% 115 75.7% 0.598
Comorbidity Musculoskeletal N (%) 259 17.8% 29 20.9% 0.370 326 24.1% 39 26.5% 0.522
Other N (%) 942 70.7% 80 69.0% 0.692 900 74.7% 85 73.9% 0.855
SF-12   PCS Mean (SD) 32.2 9.4 32.4 9.2 0.821 32.3 9.1 32.4 9.7 0.918
MCS Mean (SD) 54.8 9.9 52.9 10.4 0.046 55.6 9.4 54.0 9.0 0.009
HOOS KOOS Pain Mean (SD) 37.9 18.6 39.8 20.0 0.244 38.9 17.6 36.4 18.8 0.124
Symptoms Mean (SD) 39.8 18.5 41.9 20.6 0.252 43.7 13.5 42.0 12.4 0.178
Activities of daily life Mean (SD) 39.9 19.2 41.8 21.6 0.324 45.0 18.2 40.8 20.9 0.026
Sport Mean (SD) 18.1 18.4 21.6 21.7 0.200 10.7 14.3 11.2 15.5 0.852
Quality of life Mean (SD) 33.4 10.8 35.2 12.1 0.083 33.6 10.4 34.6 11.8 0.327
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On a total of 15 items, the median number of missing 
items for both joint locations was 0 (range 0 to 15), whereas 
the mean (SD) was 0.4 (1.9) (hip OA: 0.4 (2.0), knee OA: 
0.3 (1.8)).
Of the 164 patients with hip OA who did not complete all 
questions, 29 did not fill in any question whereas 99 missed 
only one question. Of the 154 patients with knee OA who 
did not complete all questions, 21 did not fill in any question 
and 102 persons had only one missing question.
Table 2 shows the percentage of missing values per ques-
tion. Most frequently missed was question 15 “How would 
you rate your physical fitness on a scale of 1 to 10?” for both 
hip and knee (hip 4.4% missing, knee 4.2% missing). This 
was the only question with no predefined answering options; 
instead patients had to write down the number themselves. In 
addition, in patients with hip OA question 2 “Are you able to 
walk independently outside?” (2.8% missing) and question 3 
“Are you able to (un)dress yourself?” (2.7% missing) were 
relatively often missing, while in knee OA patients ques-
tion 6 “Do you encounter problems in daily life because of 
impaired hearing?” (2.6% missing) and question 2 “Are you 
able to walk independently outside?” (2.3% missing) were 
relatively often missing.
To assess determinants for completing the GFI ques-
tionnaire a logistic regression model was build including 
age, sex, BMI, musculoskeletal and other comorbidities. 
Table 3 shows the odds ratios associated with this model. 
It was found that age and sex are statistically significant 
determinants for completing the questionnaire in persons 
with end-stage OA of the lower limb corrected for BMI and 
comorbidities.
Older age is, independent of gender, BMI and comorbidi-
ties, associated with lower odds for completing the question-
naire (OR: 0.98, P value 0.020), while for gender it was 
found that, when correcting for age, BMI, musculoskeletal 
and other comorbidities, females have higher odds for com-
pleting the questionnaire as compared to males (OR: 1.50, 
P value; 0.010). BMI and having musculoskeletal or other 
comorbidities were not statistically significant associated 
with the completing of the GFI questionnaire for persons 
with end-stage hip or knee OA.
The internal consistency of the GFI in patients 
scheduled to undergo arthroplasty was 0.69, just below 
the threshold of 0.7 of good internal consistency [31]. 
Regarding the validity of the GFI questionnaire the mental 
and physical domains of GFI were strongly to moderately 
Table 2  Percentage of missing 
per question for the Groningen 
Frailty Indicator
Hip (%) Knee (%)
1. Are you able to do groceries by yourself? 2.5 1.9
2. Are you able to walk independently outside? 2.8 2.3
3. Are you able to (un)dress yourself? 2.7 2.2
4. Are you able to use the bathroom by yourself? 2.7 2.0
5. Do you encounter problems in daily life because of impaired vision? 2.5 2.1
6. Do you encounter problems in daily life because of impaired hearing? 2.4 2.6
7. Did you unintentionally lose weight over the past 6 months? 2.4 1.8
8. Do you use 4 or more types of medication? 2.7 1.8
9. Do you have any complaints on your memory? 2.1 1.8
10. Do you experience emptiness around you? 2.2 1.8
11. Do you miss the presence of other people around you? 2.4 2.0
12. Do you feel left alone? 2.7 1.8
13. Have you felt down or depressed lately? 2.5 2.0
14. Have you felt nervous or anxious lately? 2.5 2.0
15. How would you rate your physical fitness on a scale of 1 to 10? 4.4 4.2
Table 3  Odds ratios for 
demographic characteristics 
to completing the Groningen 
Frailty Questionnaire
Characteristics were included in logistic regression analysis relating the demographic characteristics to 
completing the GFI questionnaire (yes/no)
Odds ratio 95% confidence interval P value
Age 0.981 0.966–0.997 0.020
Sex 1.497 1.100–2.038 0.010
Body mass index (BMI) 1.006 0.974–1.039 0.714
Musculoskeletal comorbidities 0.946 0.661–1.354 0.762
Other comorbidities 0.890 0.644–1.230 0.481
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correlated with the MCS of the SF-12 (R  =  −  0.59, 
P < 0.001) and the PCS (R = − 0.39, P < 0.001), respec-
tively, confirming the validity of the questionnaire. When 
performing cross-over analysis by correlating the mental 
domain of the GFI to the PCS of the SF-12 discrimina-
tory validity was confirmed with a very weak correla-
tion (R = − 0.08; P < 0.001). In addition, the correlation 
of the physical domain of the GFI and MCS had a low 
correlation of R = − 0.28 (P < 0.001). The correlation 
of the GFI with the HOOS/KOOS-pain score was, as 
hypothesized, low and also confirmed its discriminatory 
value to distinguish between pain and frailty (R = − 0.23, 
P < 0.001).
Of the 2957 patients with end-stage hip or knee OA 
who did complete the questionnaire, 853 (28.8%) were 
considered frail (a score of ≥ 4 on GFI). Patients with 
hip OA scored on average higher on the GFI [mean (SD) 
score: 2.78 (2.41) versus 2.28 (1.99)] and were more often 
considered frail as compared to persons with knee OA 
(33.3 versus 24.1%). Table 4 shows that frail persons were 
statistically significantly more often female, older and 
had a higher BMI as compared to those who are not frail. 
Also, frail persons scored statistically significantly lower 
on all scales of physical functioning of the HOOS/KOOS 
as well as on the physical and mental component scale of 
the SF-12 before arthroplasty surgery.
Discussion
The GFI is a valid questionnaire to assess frailty in end-stage 
hip or knee OA patients by means of a self-reported postal 
questionnaire. According to the GFI, using the cut-off of 4, 
about one-third of the patients undergoing THA and a quar-
ter of the persons undergoing TKA are frail.
The feasibility of the use of the GFI within the current 
clinical setting for patients with end-stage hip or knee OA 
is good, as 90% of the participants completed the question-
naire. In a study by Metzelthin et al. in older community 
dwelling persons showed that 77.4% of the persons com-
pleted the questionnaire [32].
Those who did not complete the questionnaire were more 
often male and older. The open question (question 15) was 
most often left empty, indicating that it is probably easier 
for patients to have closed questions with predefined answer 
options. Further research is needed to reconsider the format 
of this question aiming to obtain higher response rates.
Although the Cronbach’s alpha of 0.69 is just below the 
threshold of good internal consistency of 0.7, it does indicate 
that the internal consistency of the GFI in our patient group 
is satisfactory and it is comparable to the alpha of 0.68 as 
found by Peters et al. in home dwelling elderly in the Neth-
erlands [20, 31].
With respect to the convergent and discriminatory 
validity of the GFI for this specific patient group, the 
Table 4  Comparison of 
demographic characteristics 
of frail and non-frail end stage 
OA-patients
BMI body mass index, HOOS/KOOS hip disability/knee injury and osteoarthritis and outcome score, SF-12 
short form 12 questionnaire, PCS physical component scale of the SF-12, MCS mental component scale of 
the SF-12
Differences between persons who are frail and those who are not. Frail and non-frail groups were compared 
by means of a t test (continue, normally distributed variable), Mann–Whitney (continue, not normally dis-
tributed variable) or Chi square (discrete variable), whichever was appropriate. A score of ≥ 4 was consid-
ered frail
Frailty as measured by GFI 
Non-frail Frail P value
Affected joint Hip N (%) 1018 (66.7%) 509 (33.3%) < 0.001
Knee N (%) 1086 (75.9%) 344 (24.1%)
Sex Female N (%) 1216 (58.4%) 620 (73.6%) < 0.001
BMI Mean (SD) 28.07 (4.41) 28.69 (5.14) 0.002
Age Years Mean (SD) 67.07 (9.02) 68.99 (9.97) < 0.001
HOOS/KOOS Pain Mean (SD) 40.56 (17.53) 32.96 (18.45) < 0.001
Symptoms Mean (SD) 43.05 (16.25) 38.19 (16.34) < 0.001
Activities of daily life Mean (SD) 45.35 (18.22) 34.97 (18.51) < 0.001
Sport Mean (SD) 16.07 (17.54) 10.64 (14.57) < 0.001
Quality of Life Mean (SD) 34.49 (10.79) 31.06 (9.75) < 0.001
SF-12 PCS Mean (SD) 33.38 (9.52) 29.33 (7.80) < 0.001
MCS Mean (SD) 58.33 (6.79) 47.01 (11.06) < 0.001
Comorbidities Musculoskeletal N (%) 351 (17.5%) 234 (29.4%) < 0.001
Other N (%) 1248 (68.1%) 594 (84.4%) < 0.001
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magnitude of the observed associations was in line with 
our hypotheses. Our convergent validity (range − 0.6–0.4) 
was comparable to the findings of Peters et  al. (range 
0.4–0.61) [20]. The discriminatory validity in our patient 
group (range − 0.08 to − 0.3) was even stronger as com-
pared to the elderly of Peters et al. (range 0.08–0.5) [20].
Significantly more patients with end-stage hip OA were 
considered to be frail as compared to end-stage knee OA 
(hip; 33%, knee; 24%, P < 0.001). However, both these 
numbers are lower as compared to the study of Peters et al. 
who found 60% of the independent living elderly in their 
study to be frail as measured by the GFI, but the average 
age in that study was 81 years, much higher than in the 
present study (mean age 68 years) [20]. In a study among 
Romanian home-dwelling elderly (mean age 75), 75% of 
the participants were considered frail by the GFI [33]. 
These studies show that the presence of frailty shows wide 
variability depending on country, social status, diagnosis 
and age. The median and mean scores of the GFI in our 
patient group (2.00 and 2.54, respectively) were lower than 
the averages in independent living old persons found by 
Peters et al. (median 3) or reported by Metzelhin et al. and 
Drubbel et al. (means 3.8 and 3.2, respectively) [20, 32, 
34]. In both the latter studies the mean age was higher than 
in our study (77 and 73 years, respectively). The lower 
frailty score in our patient groups can, apart from age, be 
explained by the fact that all patients were selected by an 
orthopaedic surgeon to receive arthroplasty surgery and 
were thus considered to be fit enough for major surgery.
The rates of persons with OA classified as being frail 
in our study are not easy to compare with other studies, 
as different methods to ascertain frailty were employed. 
Using Fried’s Frailty Phenotype [6], Mandl et al. found 
that 8% of persons scheduled for knee arthroplasty were 
considered frail (although 17% reported difficulty with 
activities of daily life) [35], with a similar rate found in 
men with hip osteoarthritis (8%) [36] and in a study of 
persons with knee, hip or hand OA from six different Euro-
pean cohorts (10.2% considered frail) [37].
A larger proportion, i.e. 22.4% of persons with hip or 
knee OA, was considered frail using Fried’s Frailty Phe-
notype in a Brazilian study [38]. With the interpretation of 
these proportions it must be taken into account that the cri-
teria of Fried’s Frailty Phenotype [6] are to be ascertained 
by a physician and do not include activities of daily life.
Dent et al. have published an overview of the most com-
monly used frailty-questionnaires including, besides the 
GFI, three other self-reported frailty assessments: the Til-
burg Frailty Index, the PRISMA-7 and the SPQ [39]. How-
ever, none of these other three self-reported questionnaires 
have to our knowledge been used to assess the occurrence 
of frailty in persons with osteoarthritis.
Since a large proportion, about one-third of the patients 
scheduled to undergo major implant surgery are considered 
frail as scored by the self-reported GFI, the effects of frailty 
on their postoperative outcome should be assessed in future 
studies. This study has shown that the use of the GFI to dis-
criminate between frail and non-frail total joint arthroplasty 
patients is appropriate.
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